Similar Papers

Paper Title
Journal
Date
Author
Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis.
...
eBioMedicine | VOL. 80
, et. al. ...
13 May 2022
SAT0118 COMPARATIVE EFFECTIVENESS OF TOCILIZUMAB IN COMBINATION WITH METHOTREXATE VERSUS TUMOR NECROSIS FACTOR INHIBITORS (TNFIS) IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH PRIOR EXPOSURE TO TNFIS
D A Pappas ... T Blachley
Annals of the Rheumatic Diseases | VOL. 79
D A Pappas, et. al.D A Pappas ... T Blachley
01 Jun 2020
Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis.
Alberto Migliore ... Joe Zhuo
Therapeutic Advances in Musculoskeletal Disease | VOL. 13
Alberto Migliore, et. al.Alberto Migliore ... Joe Zhuo
01 Jan 2020
P106 Do high rheumatoid factor titres impact response to tumour necrosis factor inhibitors? Comparison of certolizumab pegol and adalimumab in patients with rheumatoid arthritis and high titres of rheumatoid factor: a post hoc analysis of a phase 4 trial.
Josef S Smolen ... Bernard Lauwerys
Rheumatology | VOL. 63
Josef S Smolen, et. al.Josef S Smolen ... Bernard Lauwerys
24 Apr 2024
View more papers

More From: RMD Open

Paper Title
Journal
Date
Author
Isolated anti-SS-B (La) antibodies: rare occurrence and lack of diagnostic value
Paul Cioni ... Gaëtane Nocturne
RMD Open | VOL. 11
Paul Cioni, et. al.Paul Cioni ... Gaëtane Nocturne
04 Feb 2025
Porphyromonas gingivalis associates with the presence of anti-citrullinated protein antibodies, but not with the onset of arthritis: studies in an at-risk population
Charlotte De Vries ... Karin Lundberg
RMD Open | VOL. 11
Charlotte De Vries, et. al.Charlotte De Vries ... Karin Lundberg
31 Jan 2025
Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and its open-label extension
Atul Deodhar ... Xenofon Baraliakos
RMD Open | VOL. 11
Atul Deodhar, et. al.Atul Deodhar ... Xenofon Baraliakos
31 Jan 2025
Trends to shorter diagnostic delay in spondyloarthritis patients during the last decades and association with clinical presentation: data from ASAS-COMOSPA study
Rodolfo Perez-Alamino ... Filip Van Den Bosch
RMD Open | VOL. 11
Rodolfo Perez-Alamino, et. al.Rodolfo Perez-Alamino ... Filip Van Den Bosch
31 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.